Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Robert

Showing results (111-120 of 438) with videos related to

Pageof 44
Sort By:
The EMBO Journal|February 10, 2023
Post-transcriptional polyadenylation site cleavage maintains 3'-end processing upon DNA damageRym Sfaxi, Biswendu Biswas, Galina Boldina, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
Frontiers in Immunology|December 19, 2024
Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacyBenjamin Cuiffo, Melissa Maxwell, Dingxue Yan, et al.
Cell Cycle (Georgetown, Tex.)|August 18, 2016
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell linesHélène Malka-Mahieu, Isabelle Girault, Margot Rubington, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2021
Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancersDirk Schadendorf, Caroline Robert, Reinhard Dummer, et al.
Journal of the American Heart Association|April 16, 2026
Association of Left Ventricular Function With Cerebral Small Vessel Disease and CognitionJiannan Huang, Vidishaa Jali, Caroline Robert, et al.
Cancers|June 24, 2022
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in MelanomaAudrey Melin, Émilie Routier, Séverine Roy, et al.
Cancer Research|December 3, 2008
ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathwayAhmed Hamaï, Franck Meslin, Houssem Benlalam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2013
Targeted therapy-induced radiation recallAntonin Levy, Antoine Hollebecque, Céline Bourgier, et al.
The Journal of Prevention of Alzheimer'S Disease|January 24, 2025
A point-based cognitive impairment scoring system for southeast Asian adultsWei Ying Tan, Xiangyuan Huang, Caroline Robert, et al.
Pageof 44

Showing results (111-120 of 438) with videos related to

Sort By:
Pageof 44
The EMBO Journal|February 10, 2023
Post-transcriptional polyadenylation site cleavage maintains 3'-end processing upon DNA damageRym Sfaxi, Biswendu Biswas, Galina Boldina, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
Frontiers in Immunology|December 19, 2024
Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacyBenjamin Cuiffo, Melissa Maxwell, Dingxue Yan, et al.
Cell Cycle (Georgetown, Tex.)|August 18, 2016
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell linesHélène Malka-Mahieu, Isabelle Girault, Margot Rubington, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2021
Pyrexia in patients treated with dabrafenib plus trametinib across clinical trials in BRAF-mutant cancersDirk Schadendorf, Caroline Robert, Reinhard Dummer, et al.
Journal of the American Heart Association|April 16, 2026
Association of Left Ventricular Function With Cerebral Small Vessel Disease and CognitionJiannan Huang, Vidishaa Jali, Caroline Robert, et al.
Cancers|June 24, 2022
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in MelanomaAudrey Melin, Émilie Routier, Séverine Roy, et al.
Cancer Research|December 3, 2008
ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathwayAhmed Hamaï, Franck Meslin, Houssem Benlalam, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2013
Targeted therapy-induced radiation recallAntonin Levy, Antoine Hollebecque, Céline Bourgier, et al.
The Journal of Prevention of Alzheimer'S Disease|January 24, 2025
A point-based cognitive impairment scoring system for southeast Asian adultsWei Ying Tan, Xiangyuan Huang, Caroline Robert, et al.
Pageof 44